GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (STU:9EH) » Definitions » Gross Margin %

Evolent Health (STU:9EH) Gross Margin % : 12.99% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Evolent Health Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Evolent Health's Gross Profit for the three months ended in Sep. 2024 was €73 Mil. Evolent Health's Revenue for the three months ended in Sep. 2024 was €560 Mil. Therefore, Evolent Health's Gross Margin % for the quarter that ended in Sep. 2024 was 12.99%.

Warning Sign:

Evolent Health Inc gross margin has been in long-term decline. The average rate of decline per year is -10%.


The historical rank and industry rank for Evolent Health's Gross Margin % or its related term are showing as below:

STU:9EH' s Gross Margin % Range Over the Past 10 Years
Min: 15.96   Med: 27.58   Max: 47.72
Current: 15.96


During the past 11 years, the highest Gross Margin % of Evolent Health was 47.72%. The lowest was 15.96%. And the median was 27.58%.

STU:9EH's Gross Margin % is ranked worse than
88.23% of 620 companies
in the Healthcare Providers & Services industry
Industry Median: 40.985 vs STU:9EH: 15.96

Evolent Health had a gross margin of 12.99% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Evolent Health was -10.00% per year.


Evolent Health Gross Margin % Historical Data

The historical data trend for Evolent Health's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Gross Margin % Chart

Evolent Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.34 24.66 27.58 23.42 23.45

Evolent Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.35 18.28 16.28 16.51 12.99

Competitive Comparison of Evolent Health's Gross Margin %

For the Health Information Services subindustry, Evolent Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolent Health's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Evolent Health's Gross Margin % falls into.



Evolent Health Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Evolent Health's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=422.3 / 1800.893
=(Revenue - Cost of Goods Sold) / Revenue
=(1800.893 - 1378.642) / 1800.893
=23.45 %

Evolent Health's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=72.7 / 559.882
=(Revenue - Cost of Goods Sold) / Revenue
=(559.882 - 487.178) / 559.882
=12.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Evolent Health  (STU:9EH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Evolent Health had a gross margin of 12.99% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Evolent Health Gross Margin % Related Terms

Thank you for viewing the detailed overview of Evolent Health's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolent Health Business Description

Traded in Other Exchanges
Address
1812 N. Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Evolent Health Headlines

No Headlines